The impact of the COVID-19 outbreak on acute stroke care in Slovakia: Data from across the country.

Szczegóły
Abstrakt

Tytuł:: The impact of the COVID-19 outbreak on acute stroke care in Slovakia: Data from across the country.
Autorzy:: Gdovinová Z; Department Neurology, Faculty of Medicine, P.J. Safarik University and University Hospital L. Pasteur, Košice.
Vitková M; Department Neurology, Faculty of Medicine, P.J. Safarik University and University Hospital L. Pasteur, Košice.
Baráková A; National Health Information Center, Bratislava, Slovakia.
Cvopová A; National Health Information Center, Bratislava, Slovakia.
Źródło:: European journal of neurology [Eur J Neurol] 2021 Oct; Vol. 28 (10), pp. 3263-3266. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: <2014- > : Oxford : Wiley
Original Publication: Oxford ; New York : Rapid Communications, [1994-
MeSH Terms:: COVID-19*
Stroke*/drug therapy
Stroke*/therapy
Humans ; Pandemics ; SARS-CoV-2 ; Slovakia/epidemiology ; Thrombolytic Therapy ; Time-to-Treatment
References:: Baracchini C, Pieroni A, Viaro F, et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci. 2020;41:1003-1005.
Hoyer C, Ebert A, Huttner AB, et al. Acute stroke in times of the COVID-19 pandemic. Stroke. 2020;1:2224-2227.
Rinkel LA, Prock JCM, Slot RER, et al. Impact of the COVID-19 outbreak on acute stroke care. J Neurol. 2020;20:1-6. https://doi.org/10.1007/s00415-020-10069-1.
Pop R, Quenardelle V, Hasiu A, et al. Impact of the COVID-19 outbreak on acute stroke pathways - insights from Alsace region in France. Eur J Neurol. 2020;27:1783-1787.
Meza HT, Lambea A, Saldana AS, et al. Impact of COVID-19 outbreak in reperfusion therapies of acute ischemic stroke in North-West Spain. https://doi.org/10.1111/ENE.14476.
Kritoffersen ES, Jahr SH, Thommessen B, Ronning OM. Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population. Acta Neurol Scand. 2020;1-5.
Bersano A, Kraemer M, Touze E, et al. Stroke care during the COVID-19 pandemic: experience from three large European countries. Eur J Neurol. 2020;27:1794-1800.
Caso V, Federico A. No lockdown for neurological diseases during COVID 19 pandemic infection. Neurol Sci. 2020;41:999-1001.
Zedde M, Pezzella FR, Paciaroni M, et al. Stroke care in Italy: an overview of strategies to manage acute stroke in COVID-19 time. Eur Stroke J. 2020;5:222-229.
Contributed Indexing:: Keywords: COVID-19; acute stroke; intravenous thrombolysis; thrombectomy
Entry Date(s):: Date Created: 20201113 Date Completed: 20210921 Latest Revision: 20210921
Update Code:: 20240105
DOI:: 10.1111/ene.14640
PMID:: 33185918
: Czasopismo naukowe

Full Text Finder

Background and Purpose: A few studies using data from regional databases have recently pointed to a decreased number of patients with stroke. The aim of the present study was to describe country-level data (the number of patients with stroke, the proportion of patients with acute stroke and transient ischemic attack (TIA), the proportion of patients treated with intravenous thrombolysis [IVT] or mechanical thrombectomy [MT], the door-to-needle times [DNT], and the onset-to-needle time [ONT]) during the COVID-19 pandemic in Slovakia.
Methods: The study examined data from the stroke register at the National Health Information Centre. Data from three time periods (March to April 2020; March to April 2019; January to February 2020) were compared using an independent samples t-test and the Wilcoxon-Mann-Whitney two-sample rank-sum test.
Results: The number of stroke patients admitted to hospitals in Slovakia during the COVID-19 period showed a decrease (1673 vs. 2328 in period 2 and 2155 in period 3). The proportions of patients with TIA remained the same in periods 1 and 2 (9.7% vs. 11.7%) and in periods 1 and 3 (9.7 vs. 11.8%). The percentage of patients treated with IVT during the pandemic (22.4%) did not differ from period 2 (20.0%) or period 3 (21.4%). No difference was found in the rate of MT between the COVID-19 period (10.2%) and the same period in 2019 (10.7%) and in January to February 2020 (13.1%). The median DNT remained unchanged in periods 1 (30 min), 2 (35 min) and 3 (30 min), and no differences were found in median ONT in periods 1 (130 min), 2 (130 min) and 3 (140 min).
Conclusion: We found a decreased number of stroke patients during the COVID-19 outbreak in Slovakia, but no evidence of a change in the quality of acute stroke care.
(© 2020 European Academy of Neurology.)

Informacja